The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Open accessAbstract
Target population This recommendation applies to adults with newly diagnosed single brain metastases amenable to surgical resection; however, the recommendation does not apply to relatively radiosensitive tumors histologies (i.e., small cell lung cancer, leukemia, lymphoma, germ cell tumors and multiple myeloma). Recommendation Surgical resection plus WBRT versus WBRT alone Level 1 Class I evidence supports the use of surgical resection plus post-operative WBRT, as compared to WBRT alone, in patients with good performance status (functionally independent and spending less than 50% of time in bed) and limited extra-cranial disease. There is insufficient evidence to make a recommendation for patients with poor performance scores, advanced systemic disease, or multiple brain metastases. If WBRT is used, is there an optimal dosing/fractionation schedule? Target population This recommendation applies to adults with newly diagnosed brain metastases. Recommendation Level 1 Class I evidence suggests that altered dose/fractionation schedules of WBRT do not result in significant differences in median survival, local control or neurocognitive outcomes when compared with “standard” WBRT dose/fractionation. (i.e., 30 Gy in 10 fractions or a biologically effective dose (BED) of 39 Gy10). If WBRT is used, what impact does tumor histopathology have on treatment outcomes? Target population This recommendation applies to adults with newly diagnosed brain metastases. Recommendation Given the extremely limited data available, there is insufficient evidence to support the choice of any particular dose/fractionation regimen based on histopathology. The following question is fully addressed in the surgery guideline paper within this series by Kalkanis et al. Given that the recommendation resulting from the systematic review of the literature on this topic is also highly relevant to the discussion of the role of WBRT in the management of brain metastases, this recommendation has been included below. Does the addition of WBRT after surgical resection improve outcomes when compared with surgical resection alone? Target population This recommendation applies to adults with newly diagnosed single brain metastases amenable to surgical resection. Recommendation Surgical resection plus WBRT versus surgical resection alone Level 1 Surgical resection followed by WBRT represents a superior treatment modality, in terms of improving tumor control at the original site of the metastasis and in the brain overall, when compared to surgical resection alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials
Maher, C. G., Sherrington, C., Herbert, R. D., Moseley, A. M., & Elkins, M. (2003) · Physical Therapy · doi:10.1093/ptj/83.8.713 · Cited by 4,808
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., Macdonald, J. S., & Young, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002223220802 · Cited by 3,135
Self-citationTreatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery
Vecht, C. J., Haaxma‐Reiche, H., Noordijk, E. M., Padberg, G. W., Voormolen, J. H. C., Hoekstra, F. H., Tans, J. T. J., Lambooij, N., Metsaars, J. A. L., Wattendorff, A. R., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330605 · Cited by 1,049
Mintz, A. H., Kestle, J. R. W., Rathbone, M. P., Gaspar, L. E., Hugenholtz, H., Fisher, B., Duncan, G. G., Skingley, P., Foster, G., & Levine, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961001)78:7<1470::aid-cncr14>3.0.co;2-x · Cited by 685
Self-citationLinskey, M. E., Andrews, D. W., Asher, A. L., Burri, S. H., Kondziolka, D., Robinson, P. D., Ammirati, M., Cobbs, C. S., Gaspar, L. E., Loeffler, J. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0073-4 · Cited by 507
Self-citationKalkanis, S. N., Kondziolka, D., Gaspar, L. E., Burri, S. H., Asher, A. L., Cobbs, C. S., Ammirati, M., Robinson, P. D., Andrews, D. W., Loeffler, J. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0061-8 · Cited by 412
Self-citationKurtz, J. M., Gelber, R., Brady, L. W., Carella, R. J., & Cooper, J. S. (1981) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(81)90005-5 · Cited by 331
Murray, K. J., Scott, C., Greenberg, H. M., Emami, B., Seider, M., Vora, N. L., Olson, C., Whitton, A., Movsas, B., & Curran, W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00341-6 · Cited by 314
The Role of Biologically Effective Dose (BED) in Clinical Oncology
Jones, B., Dale, R. G., Deehan, C., Hopkins, K. I., & Morgan, D. A. L. (2001) · Clinical Oncology · doi:10.1007/s001740170083 · Cited by 286
T.Komarnicky, L., Phillips, T. L., Martz, K., Asbell, S., Isaacson, S., & Urtasun, R. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90137-s · Cited by 237
Regine, W. F., Scott, C., Murray, K., et al. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01676-5 · Cited by 209
Priestman, T. J., Dunn, J., Brada, M., Rampling, R., & Baker, P. G. (1996) · Clinical Oncology · doi:10.1016/s0936-6555(05)80717-4 · Cited by 171
Prognosis of patients treated for intracranial metastases with whole-brain irradiation
Sundström, J. T. T., Minn, H. R. I., Lertola, K., & Nordman, E. (1998) · Annals of Medicine · doi:10.3109/07853899809005858 · Cited by 143
Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28
Sause, W. T., Scott, C., Krisch, R. E., Rotman, M., Sneed, P. K., Janjan, N. A., Davis, L. W., Curran, W. J., Choi, K. N., Selim, H., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90284-3 · Cited by 107
Barnard, S., & Wiles, R. (2001) · Physiotherapy · doi:10.1016/s0031-9406(05)61078-4 · Cited by 106
Robinson, P. D., Kalkanis, S. N., Linskey, M. E., & Santaguida, P. L. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0059-2 · Cited by 33
Self-citationPractical Time–Dose Evaluations, or How to Stop Worrying and Learn to Love Linear Quadratics
Fowler, J. F. (2011) · Medical radiology · doi:10.1007/174_2011_305 · Cited by 16
Practical Time-Dose Evaluations, or How to Stop Worrying and Learn to Love Linear Quadratics
Fowler, J. F. (2006) · Springer eBooks · doi:10.1007/3-540-35665-7_1 · Cited by 12
(2006) · Europe PMC (PubMed Central)
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Gondi, V., Pugh, S. L., Tome, W. A., Caine, C., Corn, B., Kanner, A., Rowley, H., Kundapur, V., DeNittis, A., Greenspoon, J. N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.2909 · Cited by 1,148
Self-citationPeters, S., Adjei, A. A., Gridelli, C., Reck, M., Kerr, K., & Felip, E. (2012) · Annals of Oncology · doi:10.1093/annonc/mds226 · Cited by 930
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Vogelbaum, M. A., Brown, P. D., Messersmith, H., Brastianos, P. K., Burri, S., Cahill, D., Dunn, I. F., Gaspar, L. E., Gatson, N. T. N., Gondi, V., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02314 · Cited by 832
Self-citation_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0021 · Cited by 735
Metadata
- Authors
- Gaspar, L. E., Mehta, M. P., Patchell, R. A., Burri, S. H., Robinson, P. D., Morris, R. E., Ammirati, M., Andrews, D. W., Asher, A. L., Cobbs, C. S., Kondziolka, D., Linskey, M. E., Loeffler, J. S., McDermott, M., Mikkelsen, T., Olson, J. J., Paleologos, N. A., Ryken, T. C., & Kalkanis, S. N.
- Venue
- Journal of Neuro-Oncology
- Published
- 2009-12-04
- Volume
- 96
- Issue
- 1
- Pages
- 17-32
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W2153022133
- Cited by
- 299
- References
- 19
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.